FDA greenlights new Alzheimer's drug amid safety concerns
The FDA is greenlighting the drug Leqembi after it appeared to slow cognitive decline in some early stage Alzheimer’s patients in spite of some potential risks. In this video, Kristen Dahlgren has more details about findings from the clinical trial.
Source: NBC News, 7 January 2023